rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Sitagliptin

Rediff.com  »  News  »   Sitagliptin

  News for Sitagliptin

  • Business

Sun Pharma, Merck to market diabetes drugs

Sun Pharmaceutical Industries Ltd and MSD in India said they have entered into a partnership to market diabetes drugs Sitagliptin and Sitaglipitin plus Metformin in the Indian market.Under the......

Merck & Co wins injunction against Indian firm over diabetes drugs

MSD, a unit of US drugmaker Merck & Co, said it has won an injunction against India's Aprica Pharmaceuticals and a source said this will stop Aprica launching generic versions of two diabetes drugs......

Drug patent row: HC to hear US co on Apr 12

Delhi High Court on Wednesday posted for April 12 an appeal filed by US pharmaceuticals major Merck Sharp and Dohme against the single judge bench order refusing to restrain Indian firm Glenmark......

MNCs' diabetes drug patents worry experts

Even as India is fast turning into the diabetes capital of the world, multinational drug companies are busy patenting new-generation diabetes medicines for exclusive marketing rights in the......
  Web results for Sitagliptin
Intarcia Secures Second Landmark Private Financing of $200 Million - Strengthens Position To Complete Phase 3, Prepare For Launch, and Build Pipeline

/PRNewswire/ --Intarcia Therapeutics, Inc. today announced the completion of another landmark private round of equity financing for $200 million .... ...

http://www.asianhhm.com/news/news_archives.asp?NewsID=67343&title=Intarcia-Secures-Second-Landmark-Private-Financing-of-$200-MillionStrengthens-Position-To-Complete-Phase-3-Prepare-For-Launch-and-Build-Pipeline
Merck HIV drug strategy in India seen shielding patent

Merck's HIV therapy, sold under the brand Isentress, is among more than 20 that an Indian government panel was preparing to assess for compulsory... ...

http://www.livemint.com/Companies/RvIYSlZNl9YqiQ5JhVEeaJ/Merck-HIV-drug-strategy-in-India-seen-shielding-patent.html
Cheap medicine myth busted

New Delhi, March 6: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies "escape routes"... ...

http://www.telegraphindia.com/1140307/jsp/frontpage/story_18054877.jsp
Lilly's phase III trial for once-weekly dulaglutide to treat type 2 diabetes achieves primary endpoint

Eli Lilly and Company, a global healthcare leader, has reported positive top-line results of the sixth AWARD (Assessment of Weekly AdministRation... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=80612&sid=2
Janssen Initiates CREDENCE Study in Patients with Type 2 Diabetes and Diabetic Nephropathy

RARITAN, N.J., Feb. 21, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced the initiation of CREDENCE... ...

http://in.sys-con.com/node/2979921

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Related Pages


sitagliptin
Sitagliptin


0 Followers

Top Coverage News


Why I love India - Independence Day Special 2013

The Rediff Independence Day Special 2013.

The Programmer Who Came In From The Cold

Whether history will remember Edward Snowden as a traitor to his country or as a champion for...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z